Article

FDA-approved laser system treats high myopia with astigmatism

The FDA has granted approval for Advanced Medical Optics’ (AMO) STAR S4 IR excimer laser system for the treatment of high myopia and myopic astigmatism.

With the CustomVue wavefront-guided LASIK procedure, indications include the reduction or elimination of myopia and myopic astigmatism from –6 to –11 D with up to –3 D of cylinder. Clinical studies found that at 6 months, in 98.3% of those who received the CustomVue high-myopia treatment vision was corrected to 20/40 or better and in 84.3% it was corrected to 20/20 or better without spectacles or corrective contact lenses, according to AMO.

CustomVue procedures for high myopia will be released to doctors certified in VISX technology over the next several weeks after they have completed the training and certification process.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.